Lee Ann Garrett-Sinha

Lee Ann Garrett-Sinha

Auto-generated profile, based on publicly available information

Lee Ann Garrett-Sinha

Department of Biochemistry, State University of New York at Buffalo, Buffalo, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
LGLee Ann Garrett-Sinha
Lee Ann Garrett-Sinha
HEHeidi Eberspaecher
Heidi Eberspaecher
MSMichael F. Seldin
Michael F. Seldin
BCBenoit de Crombrugghe
Benoit de Crombrugghe
We have identified a novel zinc-finger protein whose mRNA is expressed at high levels in the epidermal layer of the skin and in epithelial cells in the tongue, palate, esophagus, stomach, and colon of newborn mice. Expression in epithelial cells is first detected at the time of their differentiation during embryonic development. In addition, during early embryonic development there is expression in mesenchymal cells of the skeletal primordia and the metanephric kidney which is later down-regulated. The expression pattern suggests that the protein could be involved in terminal differentiation of several epithelial cell types and could also be involved in early differentiation of the skeleton and kidney. The carboxyl terminus of the protein contains three zinc fingers with a high degree of homology to erythroid krüppel-like factor and binds to DNA fragments containing CACCC motifs. The amino-terminal portion of the protein is proline and serine-rich and can function as a transcriptional activator. The chromosomal location of the gene was mapped using mouse interspecific backcrosses and was shown to localize to mouse chromosome 4 and to cosegregate with the thioredoxin gene.

1 May 2008 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
RLRegina Landesberg
Regina Landesberg
MCMatthew Cozin
Matthew Cozin
SCSerge Cremers
Serge Cremers
VWVictoria Woo
Victoria Woo
SKStavroula Kousteni
Stavroula Kousteni
SRSrikala Raghavan
Srikala Raghavan

5 January 2013 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
LGLee Ann Garrett-Sinha
Lee Ann Garrett-Sinha

1 December 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GSGloria Su
Gloria Su
HCHui‐Min Chen
Hui‐Min Chen
NMNatarajan Muthusamy
Natarajan Muthusamy
LGLee Ann Garrett‐Sinha
Lee Ann Garrett‐Sinha
DBDavid Baunoch
David Baunoch
MSM.CEleste Simon
M.CEleste Simon
Spi‐B is a hematopoietic‐specific Ets family transcription factor closely related to PU.1. Previous gene targeting experiments have shown that PU.1 is essential for the production of both lymphocytes and monocytes. We have now generated mice with a null mutation at the Spi‐B locus. Unlike PU.1 mutant mice, Spi‐B−/− mice are viable, fertile and possess mature B and T lymphocytes. However, Spi‐B−/− mice exhibit severe abnormalities in B cell function and selective T cell‐dependent humoral immune responses. First, although Spi‐B−/− splenic B cells respond normally to lipopolysaccharide stimulation in vitro , these B cells proliferate poorly and die in response to B cell receptor (surface IgM) cross‐linking. Secondly, Spi‐B−/− mice display abnormal T‐dependent antigenic responses in vivo and produce low levels of antigen‐specific IgG1, IgG2a and IgG2b after immunization. Finally, Spi‐B−/− mice show a dramatic defect in germinal center formation and maintenance. In contrast to wild‐type animals, germinal centers in Spi‐B−/− mice are smaller and short‐lived with significantly increased numbers of apoptotic B cells. Taken together, these results demonstrate that Spi‐B is essential for antigen‐dependent expansion of B cells, T‐dependent immune responses and maturation of normal germinal centers in vivo .

1 September 2008 in Current Opinion in Rheumatology
Verified
Journal Article
Closed access
LGLee Ann Garrett-Sinha
Lee Ann Garrett-Sinha
SJShinu John
Shinu John
SGSarah L Gaffen
Sarah L Gaffen
Systemic lupus erythematosus etiology includes both genetic and environmental factors. Evidence suggests that many genetic loci in humans and mouse models contribute to the occurrence and clinical presentation of lupus. This large array of different genes affects many aspects of immune cell function, including the activation and functional differentiation of B cells, T cells, dendritic cells and other immune cells. In particular, the T-cell components that contribute to systemic lupus erythematosus pathogenesis are incompletely defined. A major paradigm shift in understanding how CD4+ T cells contribute to autoimmunity recently occurred with the discovery of a new T-cell population that produces the cytokine IL-17 (IL-17A), termed 'Th17'. Although Th17 cells contribute to autoimmune disease in rheumatoid arthritis and Crohn's disease, their role in systemic lupus erythematosus is far less clear. In this review, we focus on an emerging role for the cytokine IL-17 and the cells that produce it in contributing to lupus in particular based on recent findings in animal models.

28 July 2005 in International Immunology
Verified
Journal Article
Open access
PDF file
DWDuncheng Wang
Duncheng Wang
SJShinu A. John
Shinu A. John
JCJames L. Clements
James L. Clements
DPDean H. Percy
Dean H. Percy
KBKevin P. Barton
Kevin P. Barton
LGLee Ann Garrett-Sinha
Lee Ann Garrett-Sinha
It has been shown that mice with a targeted mutation in the Ets-1 gene exhibit increased B cell terminal differentiation to IgM-secreting plasma cells. Here, we show that mice, formerly described to lack Ets-1 protein, actually express low levels of an internally deleted Ets-1 protein. Mice harboring this Ets-1 hypomorphic allele possess very few marginal zone B cells and have increased expression of activation markers on follicular B cells. Adoptive transfer experiments indicate that this activated phenotype can be reversed upon transfer of Ets-1-deficient B cells to a wild-type host, suggesting a role for B cell-extrinsic factors in regulating the activated state. Supporting this observation, the reverse transfer experiment of wild-type B cells into an Ets-1-deficient host resulted in increased expression of activation markers on the transferred B cells. However, there are also cell-intrinsic changes in Ets-1-deficient B cells as demonstrated by their increased differentiation to plasma cells in vitro in response to stimulation with cytosine-phosphate-guanine DNA sequence-containing oligodeoxynucleotide [CpG DNA, a Toll-like receptor (TLR) 9 ligand]. Consistent with the activated phenotype and increased terminal differentiation of Ets-1-deficient B cells, Ets-1 mutant mice develop autoimmune disease. Hence, our studies establish Ets-1 as an important regulator of peripheral B cell differentiation and B cell responses to TLR9 activation.